翻译尚未完成，当前显示原文。
Guinea-Bissau has reportedly halted a controversial United States-funded hepatitis B virus vaccine (HBV) trial which drew global scrutiny when experts said it involved withholding lifesaving shots from thousands of babies. The trial failed to gain the necessary government approval, one researcher involved in the project said in a statement, adding that the end of the trial was a “significant setback” for African science. The West African nation’s judicial police said in mid-October that it had raided the facilities of the research group leading the project in the capital, Bissau, and seized vaccine batches. Authorities said inquiries were continuing to determine whether the trial had complied with the country’s safety standards.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。